["{\n\"step_by_step_thinking\": \"The question asks which anticholinergic agent does not cross the blood-brain barrier. We can look at the provided documents to find information on the blood brain barrier and anticholinergic agents. Document 2 talks about central versus peripheral anticholinergic activity, mentioning that one of the test procedures measures peripheral anticholinergic activity whereas the other primarily measures anticholinergic activity in the CNS. This suggests that some anticholinergic agents can cross the blood-brain barrier. On the other hand, document 3 discusses cholinergic mechanisms and their relationship to anesthesia, but does not explicitly mention the blood brain barrier. Document 4 is about plasma cyclic GMP response to cholinergic agents and does not provide any information on the blood brain barrier either. Therefore, we need to focus on the anticholinergic agents mentioned in the question and see if they are discussed in any of the provided documents. Glycopyrrolate, atropine, hyoscine butylbromide, and hyoscine hydrobromide are all mentioned as tertiary or quaternary anticholinergic drugs. Document 2 only mentions atropine, scopolamine, and their methylnitrate derivatives. Therefore, we can conclude that the other three options might be able to cross the blood brain barrier.\",\n\"answer_choice\": B"]